SKVI SKINVISIBLE, INC.

OTC Pharmaceutical Preparations NV CIK: 0001085277
AI RATING
STRONG_SELL
98% Confidence

Investment Thesis

SKVI exhibits critical financial distress with negative stockholders' equity of -$10.3M, indicating technical insolvency. The company generates minimal revenue ($20K) while burning $1.1M in annual losses and faces acute liquidity crisis with 0.01x current ratio and $2.6K cash against $10.4M in liabilities. Absent dramatic operational turnaround or major capital injection, the company faces severe going-concern risk.

Strengths

  • + 100% gross margin demonstrates pricing power on revenue generated
  • + Ongoing SEC compliance and regulatory reporting
  • + Established debt relationships indicating prior credit market access

Risks

  • ! Negative stockholders' equity of -$10.3M: liabilities exceed assets by order of magnitude, technical insolvency
  • ! Catastrophic liquidity position: 0.01x current ratio with $2.6K cash against $10.4M liabilities
  • ! Unsustainable burn: -$42.5K free cash flow on $20K revenue, -$1.1M net loss, operating losses of $496K

Key Metrics to Watch

Financial Metrics

Revenue
20.0K
Net Income
-1.1M
EPS (Diluted)
$-0.11
Free Cash Flow
-42.5K
Total Assets
127.6K
Cash
2.6K

Profitability Ratios

Gross Margin 100.0%
Operating Margin -2,481.6%
Net Margin -5,320.2%
ROE N/A
ROA -834.1%
FCF Margin -212.5%

Balance Sheet & Liquidity

Current Ratio
0.01x
Quick Ratio
0.01x
Debt/Equity
N/A
Debt/Assets
8,145.0%
Interest Coverage
-0.87x
Long-term Debt
59.6K
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-15T23:54:25.854792 | Data as of: 2025-12-31 | Powered by Claude AI